Related Experiment Videos
Transplants in Parkinson's disease.
1Department of Neurology, University of Lund, Sweden.
European Neurology
|January 1, 1991
Summary
Neural transplantation shows promise for Parkinson's disease (PD) treatment. Fetal dopamine neuron grafts survive and improve function in PD patients, though further research is needed for therapeutic application.
Area of Science:
- Neuroscience
- Neurosurgery
- Regenerative Medicine
Background:
- Parkinson's disease (PD) is a neurodegenerative disorder characterized by dopamine deficiency.
- Current treatments offer symptomatic relief but do not halt disease progression.
- Investigational therapies include neural transplantation aiming to restore dopaminergic function.
Purpose of the Study:
- To review clinical trials of adrenal medulla and fetal substantia nigra grafts in Parkinson's disease patients.
- To discuss scientific challenges for neural transplantation as a therapeutic option for PD.
- To evaluate the potential of fetal dopamine neuron transplantation.
Main Methods:
- Review of clinical trial data for adrenal medulla autotransplantation.
- Summary of outcomes from open microsurgery procedures.
- Analysis of early clinical trials involving human fetal mesencephalic tissue transplantation into the striatum.
Main Results:
- Adrenal medulla grafts provided modest improvement in "off" periods for 30-50% of patients but had high morbidity and mortality.
- Fetal dopamine neuron grafts demonstrated survival in the parkinsonian brain.
- Transplanted fetal neurons produced therapeutically valuable functional effects in patients.
Conclusions:
- Adrenal medulla autotransplantation is an experimental approach with significant risks and is not a current treatment for PD.
- Fetal dopamine neuron transplantation shows potential as an effective therapy for Parkinson's disease.
- Further optimization of neural transplantation procedures is required to maximize therapeutic benefits for PD patients.